A conceivable strategy to prevent the oncogenic properties of YAP could also consist of negatively modulating the signaling of G-protein-coupled receptors (GPCRs) (see PAR1, Section 2.3), which are involved in multiple cancer entities [172]. The gene discussed is YAP1; the disease is cancer.